Buprenorphine 42858-0501
Product NDC
42858-0501- Manufacturer
- Rhodes Pharmaceuticals Llc
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- October 25, 2017
- Listing Expires
- December 31, 2027
- Application
- ANDA207276
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
30 TABLET in 1 BOTTLE (42858-501-03)